Mutational analysis of a neutralization epitope on the dengue type 2 virus (DEN2) envelope protein: monoclonal antibody resistant DEN2/DEN4 chimeras exhibit reduced mouse neurovirulence.
about
The role of viral persistence in flavivirus biologyStructure of yellow fever virus envelope protein domain IIIAn in-depth analysis of original antigenic sin in dengue virus infectionPrM- and cell-binding domains of the dengue virus E protein.The H gene of rodent brain-adapted measles virus confers neurovirulence to the Edmonston vaccine strain.Attenuation of Murray Valley encephalitis virus by site-directed mutagenesis of the hinge and putative receptor-binding regions of the envelope protein.Monoclonal Antibodies That Bind to Domain III of Dengue Virus E Glycoprotein Are the Most Efficient Blockers of Virus Adsorption to Vero CellsInfectious cDNA clone of the epidemic west nile virus from New York CityA functional epitope determinant on domain III of the Japanese encephalitis virus envelope protein interacted with neutralizing-antibody combining sites.West Nile virus in complex with the Fab fragment of a neutralizing monoclonal antibodyCuration of viral genomes: challenges, applications and the way forwardGeneration and Characterization of Monoclonal Antibodies against Dengue Virus Type 1 for Epitope Mapping and Serological Detection by Epitope-Based Peptide AntigensSolution structure of the envelope protein domain III of dengue-4 virusType- and Subcomplex-Specific Neutralizing Antibodies against Domain III of Dengue Virus Type 2 Envelope Protein Recognize Adjacent EpitopesNMR solution structure and backbone dynamics of domain III of the E protein of tick-borne Langat flavivirus suggests a potential site for molecular recognitionGenetic Determinants of Sindbis Virus Mosquito Infection Are Associated with a Highly Conserved Alphavirus and Flavivirus Envelope SequenceMonoclonal Antibodies That Bind to Common Epitopes on the Dengue Virus Type 2 Nonstructural-1 and Envelope Glycoproteins Display Weak Neutralizing Activity and Differentiated Responses to Virulent Strains: Implications for Pathogenesis and VaccinesCharacterization of Dengue Virus Complex-Specific Neutralizing Epitopes on Envelope Protein Domain III of Dengue 2 VirusDifferential Cholesterol Binding by Class II Fusion Proteins Determines Membrane Fusion PropertiesHumoral Immune Responses of Dengue Fever Patients Using Epitope-Specific Serotype-2 Virus-Like Particle AntigensProgress on the development of therapeutics against West Nile virusAntibodies Induced by Dengue Virus Type 1 and 2 Envelope Domain III Recombinant Proteins in Monkeys Neutralize Strains with Different GenotypesThe Development of Therapeutic Antibodies That Neutralize Homologous and Heterologous Genotypes of Dengue Virus Type 1Structural basis of a flavivirus recognized by its neutralizing antibody: solution structure of the domain III of the Japanese encephalitis virus envelope proteinStructural Analysis of a Dengue Cross-Reactive Antibody Complexed with Envelope Domain III Reveals the Molecular Basis of Cross-ReactivityDengue-1 envelope protein domain III along with PELC and CpG oligodeoxynucleotides synergistically enhances immune responsesA novel single-dose dengue subunit vaccine induces memory immune responsesStructural basis of West Nile virus neutralization by a therapeutic antibodyVariable surface epitopes in the crystal structure of dengue virus type 3 envelope glycoproteinPhage display approaches for the isolation of monoclonal antibodies against dengue virus envelope domain III from human and mouse derived libraries.A human PrM antibody that recognizes a novel cryptic epitope on dengue E glycoprotein.Roles of the fusion and hemagglutinin-neuraminidase proteins in replication, tropism, and pathogenicity of avian paramyxoviruses.A High-Performance Multiplex Immunoassay for Serodiagnosis of Flavivirus-Associated Neurological Diseases in Horses.Development of effective therapies against West Nile virus infection.Evaluation of the maturation of individual Dengue virions with flow virometry.Alterations of pr-M cleavage and virus export in pr-M junction chimeric dengue viruses.Epitope determinants of a chimpanzee Fab antibody that efficiently cross-neutralizes dengue type 1 and type 2 viruses map to inside and in close proximity to fusion loop of the dengue type 2 virus envelope glycoprotein.Domain III of the envelope protein as a dengue vaccine target.Neuroinvasive flavivirus infections.Molecular determinants of dengue virus 2 envelope protein important for virus entry in FcγRIIA-mediated antibody-dependent enhancement of infection.
P2860
Q22809893-D3261CF4-6283-44E5-AE1A-DACF98513D56Q24289393-D0DC76D1-46F0-4B71-869E-843AEBF61D0EQ24606493-C51B9125-E17C-42AC-8A67-D57E0A6DC002Q27469382-B4C8A656-090A-4F2E-B071-34A32DCF2A02Q27469722-8DA9845C-8686-49B2-99C3-E3A499CB36F1Q27469932-F04E01C9-4793-42CB-8C7F-F0E32A8952F3Q27469935-9793DD3A-EF8E-43B9-AD3A-8B437A671D5FQ27472878-8E3D9664-82AC-4C83-A8FB-B3E7A87794C8Q27473104-124DD63E-8086-43BF-A1AC-F155E1A23727Q27477479-479B2F42-459A-4F24-87EC-6B5D4E044617Q27477939-C0773D4F-A9C3-4A13-8BA2-A1D2CC8077B0Q27478354-2E01E046-6018-4F0C-93E5-8855CD617B89Q27480990-EAE93459-C5A2-4BB8-9981-EF8936569515Q27485031-CB6C486C-E0A4-4D54-AD42-7593D722DF86Q27485383-E9139EAC-D15B-47C5-B000-D655887DF002Q27485453-3468FA95-85B2-4ECF-8F5E-152EA3F74F79Q27485490-8B141D74-070A-4EA8-B155-508D9572ED4DQ27486788-D6A3FDA9-EB0E-4FF1-BEA6-2DA73AFC9101Q27486916-8F1A4114-A868-4A8F-A1C1-C246EAE1209BQ27488243-E3A19BC4-9D3D-48BA-913C-951E003AF93AQ27489893-56F8ADAF-41D9-4BF2-9885-29F5319CFA2FQ27490452-74BB3ADA-2F0C-4E01-BCAB-F5D6603C806AQ27491317-A7183DED-54F8-47A2-86BC-C8F484F0EDC8Q27641947-FD9FB14B-426C-410A-9254-C4C1497EA127Q27678419-A08F9700-18A9-4655-94BE-7479F9CAB68FQ28729951-90FC6F29-EE26-41A2-873D-61CBA63F38BCQ28741828-AE4F6A87-2D88-4FEB-B860-867237BEBEFDQ29618168-A28F4027-2F15-44A2-8ACA-8CB78851A651Q29618169-E4227D58-2217-4EBE-A1C7-3307F2805669Q34226542-BF5CC7D4-F49F-4D33-9D6E-12C0D0237C0EQ34235005-B808BF33-9817-4B15-9548-C5B6D21ABCF8Q35192881-9908A782-8913-47D2-8BF7-9F60D7BFD626Q36109311-130415BC-464E-4D24-A530-4275BD16C0C2Q36322125-698483D4-7C0A-42D2-B62E-9E0811189763Q36553879-E9E0C34B-5FDA-417E-9EA5-D4896BBFCD1BQ36953896-24867C35-87DC-4302-A2D9-FDEE4AC73D26Q37596501-D94C24A8-4D9C-4F03-BA75-114FFCAE628EQ37682895-42203807-F1EF-46E4-B062-6F0858CCAB39Q37956596-9DB7E6A9-4C91-4747-B820-3873B3A2F943Q38989101-14295C2E-13CE-4CEB-997E-EA1B5DB3BDC3
P2860
Mutational analysis of a neutralization epitope on the dengue type 2 virus (DEN2) envelope protein: monoclonal antibody resistant DEN2/DEN4 chimeras exhibit reduced mouse neurovirulence.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
1996年论文
@zh
1996年论文
@zh-cn
name
Mutational analysis of a neutr ...... reduced mouse neurovirulence.
@en
type
label
Mutational analysis of a neutr ...... reduced mouse neurovirulence.
@en
prefLabel
Mutational analysis of a neutr ...... reduced mouse neurovirulence.
@en
P2093
P356
P1433
P1476
Mutational analysis of a neutr ...... reduced mouse neurovirulence.
@en
P2093
P304
P356
10.1006/VIRO.1996.0550
P407
P577
1996-10-01T00:00:00Z